Colorectal cancer (CRC) is the second most diagnosed disease worldwide. It is the fourth
leading cause of cancer related mortalities. Higher probability for the occurrence of CRC is …

Important developments in chemotherapy for metastatic colorectal cancer over the last years
are reviewed, with an emphasis on the most recently published data from clinical trials. The …

New strategies are being investigated to ameliorate the efficacy and reduce the toxicity of
the drugs currently used in colorectal cancer (CRC), one of the most common malignancies …

The epidermal growth factor receptor (EGFR) is involved in development and progression of
some gastrointestinal cancers, and is targeted by monoclonal antibodies (mAbs) and …

Health-related quality is of life of great importance in cancer care. This prospective study
aimed to evaluate the impact of chemotherapy and bevacizumab on the activities of daily …

Background This study aims to test the validity and reliability of the Turkish version of the
European Organization for Research and Treatment of Cancer, Quality of Life Questionnaire …

Bu araştırma “Kolorektal Kanserli Hastalarda Yaşam Kalitesi”(KKHYK)[European
Organisation for Research and Treatment of Cancer, Quality of Life Questionnaire …

Cancer chemotherapy has transitioned from the use of cytotoxic drugs to the era of agents
with an apparent selectivity for a cancer‐specific target. The past decade has provided …

Polypharmacology is frequently referred to the design or use of pharmaceutical agents that
act on multiple molecular targets or multiple signaling pathways for multifactorial human …

Health-related quality of life (HRQoL) is a multidimensional concept that measures how a
disease and the treatment of that disease impact a patient's life. It can also aid in the …